Title:
PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/242753
Kind Code:
A1
Abstract:
The present disclosure relates to a pharmaceutically acceptable salt of a pyrazoloheteroaryl derivative and a crystal form thereof. In particular, the present disclosure relates to a pharmaceutically acceptable salt of a compound represented by formula (I), and a crystal form thereof. The novel crystal form of the present disclosure has good physical and chemical properties.
Inventors:
YAO JIAQI (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
YANG JUNRAN (CN)
DU ZHENXING (CN)
Application Number:
PCT/CN2022/094161
Publication Date:
November 24, 2022
Filing Date:
May 20, 2022
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D471/04; A61K31/5377; A61P35/00; C07D519/00
Domestic Patent References:
| WO2021098811A1 | 2021-05-27 | |||
| WO2021098811A1 | 2021-05-27 | |||
| WO2016020320A1 | 2016-02-11 |
Foreign References:
| CN112654396A | 2021-04-13 | |||
| CN108699057A | 2018-10-23 | |||
| CN106795156A | 2017-05-31 | |||
| CN202110558670A | 2021-05-21 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: METHOD FOR PREPARING BTK INHIBITOR INTERMEDIATE
Next Patent: CIRCUIT BOARD AND ELECTRONIC APPARATUS
Next Patent: CIRCUIT BOARD AND ELECTRONIC APPARATUS